Pemphigoid diseases (PD) are a group of severe and difficult to treat autoimmune blistering lacking therapeutic options that specifically target molecular structures at the dermal-epidermal junction. Treatment PD is still based on high-dose corticosteroids which bare risk life-threatening side effects. As one representative PD, epidermolysis bullosa acquisita (EBA) caused by autoantibodies targ...